Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal
Riley J Lizotte,1 John A Kappes,2 Billie J Bartel,2 Katie M Hayes,1 Veronica L Lesselyoung1 1Pharmacy Department, Rapid City Regional Hospital, Rapid City, SD, USA; 2Pharmacy Practice, South Dakota State University, Brookings, SD, USA Background: In severe alcohol withdrawal (AW), benzodiazepines...
Guardado en:
Autores principales: | Lizotte RJ, Kappes JA, Bartel BJ, Hayes KM, Lesselyoung VL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9299401976194957b8018a7adc4e8885 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
por: Rena Eudy‐Byrne, et al.
Publicado: (2021) -
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
por: Sunkaraneni S, et al.
Publicado: (2017) -
Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review
por: Brennan JL, et al.
Publicado: (2013) -
Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers
por: Farr SJ, et al.
Publicado: (2015) -
Effects of propofol and its formulation components on macrophages and neutrophils in obese and lean animals
por: Luciana Boavista Barros Heil, et al.
Publicado: (2021)